about
In vitro evaluation of a soluble Leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasisUnravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease developmentRole of CD8(+) T cells in protection against Leishmania donovani infection in healed Visceral Leishmaniasis individuals.Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cellsTolerance to Trypanosomatids: A Threat, or a Key for Disease Elimination?Trypanosoma musculi Infection in Mice Critically Relies on Mannose Receptor-Mediated Arginase Induction by a TbKHC1 Kinesin H Chain Homolog.In situ detection of antigen-specific tumor-infiltrating lymphocytes using newly designed tetramers.Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics."Pathogeno-proteomics".Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages?Design of multi-epitope peptides containing HLA class-I and class-II-restricted epitopes derived from immunogenic Leishmania proteins, and evaluation of CD4+ and CD8+ T cell responses induced in cured cutaneous leishmaniasis subjectsPeptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis
P50
Q33559668-135CD1DE-761A-44FE-807C-F72499647D49Q34466454-048697CC-CBF8-4BF6-BCAB-B5CDBAC7F274Q34645661-5BE004DC-F1D3-4F94-A78C-ECA9751C6DE5Q35116374-93F7F68B-019D-405A-9014-56695E2750C1Q36028999-C3E376DC-30BE-4367-8CE7-47EE674EDB67Q37123713-28B68364-4536-499E-BF39-53A268FA4838Q38661478-02A85643-7856-443A-A6E3-6D690B432A22Q40121679-C416AF02-A046-4FCC-AED3-5FE9152CAFDEQ40634878-DC9B62E0-853B-4FFC-9525-0CC09A25D11FQ40765719-1EFF3C70-44E5-4C32-8A45-D984465C2D0FQ46260367-0DC11448-58F4-4615-9A94-C79B1F9E6884Q51671704-937E8BE6-B5CD-4FF9-ADFC-9A5A874F9AC5Q53685684-E0CF221D-E2E4-436D-82BD-ED6F7EA041F1Q90356403-ED316235-3547-4B18-B418-CAD43B8A74AFQ91792244-43D187B5-3D72-47F1-9FF9-C20F98CF7D2A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rachel Bras-Gonçalves
@ast
Rachel Bras-Gonçalves
@en
Rachel Bras-Gonçalves
@es
Rachel Bras-Gonçalves
@nl
type
label
Rachel Bras-Gonçalves
@ast
Rachel Bras-Gonçalves
@en
Rachel Bras-Gonçalves
@es
Rachel Bras-Gonçalves
@nl
prefLabel
Rachel Bras-Gonçalves
@ast
Rachel Bras-Gonçalves
@en
Rachel Bras-Gonçalves
@es
Rachel Bras-Gonçalves
@nl
P1053
I-8520-2016
P106
P21
P31
P3829
P496
0000-0002-3089-4530